SV

Street Verdict

Analyst Scorecard

A record of what Rahul Sharma said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the Pharma index, which is breaking out of a multi-month consolidation around the 22,200 area. Expects the index to rise by 5% to 8% from current levels over the next couple of months, with old economy pharma stocks like Sun Pharma, Divi’s Labs, and Biocon doing well.”

Rahul Sharma’s track record (trackable calls only): 34 graded calls · 95% CI 37–69%

Nifty PharmaBullishCalled 03 Jul 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Rahul Sharma’s full track record